Renal denervation in resistant hypertension: Proposal for a common multidisciplinary attitude;Dénervation rénale pour le traitement de l'hypertension artérielle résistante: Proposition pour une attitude multidisciplinaire commune

Revue Medicale Suisse

Volumn 8, Issue 343, 2012, Pages 1159-1163

  Muller, O ^a   Qanadli, S D ^a   Waeber, B ^a   Wuerzner, G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HIGH RISK PATIENT; HUMAN; KIDNEY DENERVATION; MEDICAL SPECIALIST; PATIENT SAFETY; PATIENT SELECTION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREVALENCE; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; RISK ASSESSMENT; SHORT SURVEY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DENERVATION; HUMANS; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; KIDNEY; PRACTICE GUIDELINES AS TOPIC; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 84864003595     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:2043-50.
2. Lewington S, et al. Age-specific relevance of usual blood pressure to vascular mortality : A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Pubitemid 35472129)
3. Chobanian AV, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure : The JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
4. * Daugherty SL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012;125:1635-42.
5. ** Calhoun DA, et al. Resistant hypertension : Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:510-26.
6. Mahfoud F, et al. Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment. Dtsch Med Wochenschr 2011;136:2418.
7. Pathak A, et al. Dénervation rénale pour le traitement de l'hypertension artérielle. Société française d'hypertension artérielle, Consensus d'expert, 2012:1-7. www.sfhta.org
8. Schmieder RE, et al. ESH Position Paper : Renal denervation - an interventional therapy of resistant hypertension. J Hypertens 2012;30:837-41.
9. Cassat M, et al. Renal sympathetic denervation : Perspective of a promising treatment for hypertension. Rev Med Suisse 2011;7:1743-7.
10. De Benedetti E. Catheter-based treatment of drug-resistant hypertension. Rev Med Suisse 2011;7:2242-4.
11. Resnic FS, Normand SLT. Postmarketing surveillance of medical devices - filling in the gaps. N Engl J Med 2012;366:875-7.
12. Kramer DB, Xu S, Kesselheim AS. Regulation of medical devices in the United States and European Union. N Engl J Med 2012;366:848-55.
13. Krum H, et al. Catheter-based renal sympathetic denervation for resistant hypertension : A multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275-81.
14. The Symplicity HTN-1 Investigators. Catheter-based renal sym pathetic denervation for resistant hypertension : Durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911-7.
15. ** The Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial) : A randomised controlled trial. Lancet 2010;376:1903-9.
16. Burnier M, et al. Electronic compliance monitoring in resistant hypertension : The basis for rational therapeutic decisions. J Hypertens 2001;19:335-41. (Pubitemid 32116286)